DIMS-9022

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDIMS-9022
Drug Alias NameDNA-based immunomodulatory sequence (InDex)DIMS-9022
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionB-lymphocyte antigen CD20 stimulantsToll like receptor 9 agonistsImmunoglobulin epsilon Fc receptor agonists
TargetsToll like receptor 9Immunoglobulin epsilon Fc receptorB-lymphocyte antigen CD20
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInDex Pharmaceuticals Holding AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInDex Pharmaceuticals Holding AB
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A